We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CRBU market cap is 128.35M. The company's latest EPS is USD -1.6032 and P/E is -0.84.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 3.56M | 2.43M | 3.46M | 2.02M | 2.08M |
| Operating Income | -37.45M | -46M | -43.5M | -38.74M | -38.88M |
| Net Income | -34.51M | -41.23M | -37.7M | -34.68M | -35.49M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.6M | 13.85M | 34.48M | 9.99M |
| Operating Income | -66.98M | -106.4M | -116.07M | -166.62M |
| Net Income | -66.92M | -99.42M | -102.07M | -149.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 432.21M | 406.83M | 372.94M | 344.33M | 313.31M |
| Total Liabilities | 63.81M | 63.54M | 62.47M | 63.13M | 60.36M |
| Total Equity | 368.4M | 343.29M | 310.46M | 281.2M | 252.95M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 442.36M | 373.77M | 432.21M | 313.31M |
| Total Liabilities | 54.53M | 72.89M | 63.81M | 60.36M |
| Total Equity | 387.83M | 300.87M | 368.4M | 252.95M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -93.29M | -37.2M | -70.07M | -102.73M | -138.2M |
| Investing | -68.18M | 22.96M | 44.16M | 70.68M | 86.61M |
| Financing | 154.3M | 12.49M | 12.62M | 12.86M | 16.72M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.52M | -90.97M | -93.29M | -138.2M |
| Investing | -176.4M | -93.25M | -68.18M | 86.61M |
| Financing | 433.43M | 2.13M | 154.3M | 16.72M |
| Market Cap | 128.35M |
| Price to Earnings Ratio | -0.84 |
| Price to Sales Ratio | 12.56 |
| Price to Cash Ratio | 7.71 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 93M |
| Average Volume (1 week) | 1.18M |
| Average Volume (1 Month) | 1.26M |
| 52 Week Change | -16.87% |
| 52 Week High | 2.9995 |
| 52 Week Low | 0.66 |
| Spread (Intraday) | 0.04 (2.86%) |
| Company Name | Caribou Biosciences Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.cariboubio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
